Ignite Creation Date:
2025-12-24 @ 9:50 PM
Ignite Modification Date:
2026-06-02 @ 4:35 AM
Study NCT ID:
NCT05804032
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-03-07
First Post:
2023-03-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Lenalidomide, Bortezomib and Dexamethasone Induction Therapy with Either Intravenous or Subcutaneous Isatuximab in Patients with Newly Diagnosed Multiple Myeloma
Sponsor:
University of Heidelberg Medical Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Multiple Myeloma | View |